surmount-1 trial tirzepatide weight loss nondiabetic non-diabetic obesity In the (published in NEJM in July 2022), adults with #obesity treated with weekly tirzepatide, a glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor surmount-1 Tirzepatide vs. Semaglutide for Patients

Nutrition on tirzepatide The most critical mistake patients make on tirzepatide is not eating enough protein

One possible reason for this observation could be the opposing chronotropic effects of SGLT2 inhibitors and GLP-1RA discussed in the sections above

Let our experienced team help you build a sustainable path to better health

High selenium and selenosis: the risk most sites underplay Here is the point most selenium articles skip

Replacement therapy addresses both the hormonal component of prostate inflammation and the sleep disruption it causes

This can be because many assume that after starting medications, they no longer need to exercise or eat healthy food